No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".
Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Forte Biosciences, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
FH
Federated Hermes, Inc.
|
2.1M | 9.94% | +345.0K (+19.5%) | 2025 | 0.1% | |
|
Shares held by quarter
Peak holding2.1M (Q2'26)
Change over 8 quarters+2.1M
Share of the company9.940%
|
||||||
|
OA
Orbimed Advisors LLC
|
1.6M | 7.43% | +380.8K (+31.8%) | 2024 | 0.6% | |
|
Shares held by quarter
Peak holding1.6M (Q2'26)
Change over 8 quarters+1.6M
Share of the company7.430%
|
||||||
28 more super investors behind a free account
See every manager holding Forte Biosciences, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FH
Federated Hermes Equity Funds
|
$95.9M | 1.3M | 5.90% | 1.95% | July 31, 2026 |
|
FH
Federated Hermes Equity Funds
|
$63.7M | 832.1K | 3.92% | 2.24% | July 31, 2026 |
23 more funds behind a free account
See every fund holding Forte Biosciences, Inc. and how much of the fund the position is.
Sign up freeLoading...